In humans, IDH1 and IDH2 perform similar functions and share considerable sequence similarity.[16] A mutation in either IDH1 or IDH2 has been shown to be a very early event in the development of low-grade gliomas. This evidence concerns the gene IDH2 and central nervous system cancer.